Food and Drug Administration

Hedge Funds Target Novo’s $16.5 Billion Trouble Magnet

FOIAengine: Catalent Targeted by 259 FOIA Requests Since 2020 Wall Street got unusually curious last...

Sarepta Faces Scrutiny from Press, Investors, Lawyers —...

FOIAengine: Maker of Elevidys Targeted by 91 FOIA Requests in 19 Months As biotech firm...

ExodusPoint Gains A Unique Advantage

FOIAengine: Decoding How a Hedge Fund Tracks FDA Requests ExodusPoint burst onto the hedge fund...

Questions About High-Flying Insulet Corp.

FOIAengine: Multiple Hedge Funds Seeking Inspection Reports Leading medical device manufacturer Insulet Corporation’s stock price...

New Questions about FDA and Pharma

FOIAengine: Revolving Door Hits Pfizer on the Way Out The revolving door between the Food...

Media Seeks Kennedy’s Recent FDA Contacts

FOIAengine: HHS Designee Is Target After Calling FDA “Corrupt” Freedom of Information Act requests from...

The Agony Around Ecstasy

FOIAengine: Media Requests Signaled Issues for a “Party Drug” Going Mainstream With 153 clinical trials...

The Glomar Hustle

FOIAengine Explores the Widespread Use of “Neither Confirm Nor Deny” By John A. Jenkins We’re taking...